Abstract:OBJECTIVE:To generate a new strain of HBeAg transgenic mice using CRISPR/Cas9 technique. METHODS:Hepatitis B virus (HBV) HBeAg gene was cloned and inserted in the pliver-HBeAg expression frame at the site of Rosa26 gene using CRISPR/Cas9 and homologous recombination techniques to construct the pliver-HBeAg expression vector containing HBeAg gene. The linear DNA fragment containing HBeAg gene was obtained by enzyme digestion. Cas9 mRNA, gRNA and the donor vector were microinjected into fertilized eggs of C57BL/6J mice, which were then transplanted into the uterus of C57BL/6J female surrogate mice to obtain F0 generation mice. The F0 generation mice were identified by long fragment PCR to obtain F0 transgenic mice with HBeAg gene. The positive F0 generation mice were bred with wild-type C57BL/6J mice to produce the F1 mice, which were identified by PCR and sequencing. The positive F1 transgenic mice carrying HBeAg gene were backcrossed until the homozygous offspring transgenic mice were obtained. The genotypes of the offspring mice were identified. The expressions of HBeAg and HBeAb in the heterozygous and homozygous HBeAg transgenic mice were detected by automatic chemiluminescence immunoassay, immune colloidal gold technique and immunohistochemistry method. RESULTS:A total of 56 F0 mice were obtained, and 2 of them carried homologous recombined HBeAg gene. Six positive F1 mice were obtained, from which 22 homozygous and 29 heterozygous F2 generation HBeAg transgenic mice were obtained. High concentration of HBeAg protein was detected in the peripheral blood of all the positive HBeAg transgenic mice without HBeAb expression. HBeAg expression was detected in the hepatocytes of HBeAg transgenic mice. CONCLUSIONS:We obtained a new strain of HBeAg transgenic mice with stable expression of HBeAg in the hepatocytes and immune tolerance to HBeAg using CRISPR/Cas9 technique, which provide a new animal model for studying HBV.

Functional Assessment of Expression of Cre Recombinase Targeting the Liver of Transgenic Mice Regulated by Tet-on and Cre/loxP System

Establishment of Triple Transgenic Mice Conditionally Expressing Hepatitis C Virus NS3/4A Protease Simultaneously Controlled by Tet-on and Cre/loxP Systems

Generation and Characterization of Transgenic Mice Expressing Tamoxifen-Inducible Cre-Fusion Protein Specifically in Mouse Liver.

Design and construction of HCV NS5B eukaryotic expression vector with Tet-on and Cre/loxP system

Establishment of a novel triple-transgenic mouse: conditionally and liver-specifically expressing hepatitis C virus NS3/4A protease

Liver steatosis of transgenic mice expressing hepatitis C virus structural proteins

[Establish a Transgenic Mice Model Harboring Structural Genes of Hepatitis C Virus].

Generation of conditionally controlled transgenic mice expressing hepatitis C virus NS3/4A protease

Generation of transgenic mice with liver-specific expression of delta drosophila homolog-like 1

Development of a System for Monitoring Specific Hepatitis C Virus NS3/4Aprotease Activity in Live Mice

Generation of H11-albumin-rtTA Transgenic Mice: A Tool for Inducible Gene Expression in the Liver

Construction and Tissue Specific Expression of Cre Transgenic Mice

Aberrant transcription and post-transcriptional processing of hepatitis C virus non-structural genes in transgenic mice

Expression of Cre Recombinase in an Enhancer-Cre Transgenic Mouse

Establishment of a mouse model of vascular endothelial-mesenchymal transdifferentiation genetic tracing and its role in liver fibrosis studies

Conditional Gene Modification in Mouse Liver Using Hydrodynamic Delivery of Plasmid Dna Encoding Cre Recombinase

A Mouse Model of Inducible Liver Injury Caused by Tet-on Regulated Urokinase for Studies of Hepatocyte Transplantation.

A spatiotemporally controlled recombinant cccDNA mouse model for studying HBV and developing drugs against the virus

[Generation of a Novel HBeAg Transgenic Mice Using CRISPR/Cas9 Technique].

Conditional Inducible Triple-Transgenic Mouse Model For Rapid Real-Time Detection Of Hcv Ns3/4a Protease Activity

Characterisation of Liver Pathogenesis, Human Immune Responses and Drug Testing in a Humanised Mouse Model of HCV Infection